C-natriuretic peptide: An important regulator of cartilage

Molecular Genetics and Metabolism

Volumn 92, Issue 3, 2007, Pages 210-215

  Pejchalova, Katerina ^a   Krejci, Pavel ^a,b,c   Wilcox, William R ^a,d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MASARYK UNIVERSITY   (Czech Republic)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C natriuretic peptide; Cartilage; Chondrocyte; Fibroblast growth factor receptor 3; Natriuretic peptide receptor; Review

Indexed keywords

NATRIURETIC PEPTIDE TYPE C;

BONE GROWTH; CARTILAGE CELL; CARTILAGE MATRIX; CELL PROLIFERATION; ENCHONDRAL OSSIFICATION; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARTILAGE; CHONDROCYTES; HOMEOSTASIS; HUMANS; NATRIURETIC PEPTIDE, C-TYPE; SIGNAL TRANSDUCTION;

MAMMALIA; MUS;

EID: 34848916087     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.06.014     Document Type: Review

References (51)

1. Rosenzweig A., and Seidman C. Atrial natriuretic factor and related peptide hormones. Annu. Rev. Biochem. 60 (1991) 229-255
2. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27 (2006) 47-72
3. Wu C.F., Wu F., Pan J., Morser J., and Wu Q. Furin-mediated processing of Pro-C-type natriuretic peptide. J. Biol. Chem. 278 (2003) 25847-25852
4. Alfonzo M.J., de Aguilar E.P., de Murillo A.G., de Villarroel S.S., de Alfonzo R.G., Borges A., and de Becemberg I.L. Characterization of a G protein-coupled guanylyl cyclase-B receptor from bovine tracheal smooth muscle. J. Recept. Signal. Transduct. Res. 26 (2006) 269-297
5. Schiller P.W., Bellini F., Dionne G., Maziak L.A., Garcia R., DeLéan A., and Cantin M. Synthesis and activity profiles of atrial natriuretic peptide (ANP) analogs with reduced ring size. Biochem. Biophys. Res. Commun. 138 (1986) 880-886
6. Schulz S. C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 26 (2005) 1024-1034
7. Maack T., Suzuki M., Almeida F.A., Nussenzveig D., Scarborough R.M., McEnroe G.A., and Lewicki J.A. Physiological role of silent receptors of atrial natriuretic factor. Science 238 (1987) 675-678
8. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K., and Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130 (1992) 229-239
9. Chusho H., Tamura N., Ogawa Y., Yasoda A., Suda M., Miyazawa T., Nakamura K., Nakao K., Kurihara T., Komatsu Y., Itoh H., Tanaka K., Saito Y., Katsuki M., and Nakao K. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl. Acad. Sci. USA 98 (2001) 4016-4021
10. Newman B., and Wallis G.A. Skeletal dysplasias caused by a disruption of skeletal patterning and endochondral ossification. Clin. Genet. 63 (2003) 241-251
11. Schlossmann J., Feil R., and Hofmann F. Insights into cGMP signalling derived from cGMP kinase knockout mice. Front. Biosci. 10 (2005) 1279-1289
12. Ammendola A., Geiselhoringer A., Hofmann F., and Schlossmann J. Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta. J. Biol. Chem. 276 (2001) 24153-24159
13. Vaandrager A.B., Edixhoven M., Bot A.G., Kroos M.A., Jarchau T., Lohmann S., Genieser H.G., and de Jonge H.R. Endogenous type II cGMP-dependent protein kinase exists as a dimer in membranes and can be functionally distinguished from the type I isoforms. J. Biol. Chem. 272 (1997) 11816-11823
14. Pfeifer A., Klatt P., Massberg S., Ny L., Sausbier M., Hirneiss C., Wang G.X., Korth M., Aszodi A., Andersson K.E., Krombach F., Mayerhofer A., Ruth P., Fassler R., and Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 17 (1998) 3045-3051
15. Chikuda H., Kugimiya F., Hoshi K., Ikeda T., Ogasawara T., Kamekura S., Ogata N., Nakamura K., Chung U.I., and Kawaguchi H. Mutation in cGMP-dependent protein kinase II causes dwarfism in a rat mutant KMI through uncoupling of proliferation and differentiation of chondrocytes. J. Bone Miner. Metab. 23 (2005) 200-204
16. Pfeifer A., Aszodi A., Seidler U., Ruth P., Hofmann F., and Fassler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 274 (1996) 2082-2086
17. Murray F., MacLean M.R., and Pyne N.J. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Br. J. Pharmacol. 137 (2002) 1187-1194
18. Kaupp U.B., and Seifert R. Cyclic nucleotide-gated ion channels. Physiol. Rev. 82 (2002) 769-824
19. Brandt R.R., Mattingly M.T., Clavell A.L., Barclay P.L., and Burnett J.C. Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo. Hypertension 30 (1997) 184-190
20. Bord S., Ireland D.C., Moffatt P., Thomas G.P., and Compston J.E. Characterization of osteocrin expression in human bone. J. Histochem. Cytochem. 53 (2005) 1181-1187
21. Garbers D.L., and Lowe D.G. Guanylyl cyclase receptors. J. Biol. Chem. 269 (1994) 30741-30744
22. Potter L.R., and Hunter T. Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor. J. Biol. Chem. 273 (1998) 15533-15539
23. Koller K.J., de Sauvage F.J., Lowe D.G., and Goedell D.V. Conservation of kinaselike domain is essential for activation of the natriuretic peptide receptor family. Mol. Cell. Biol. 12 (1992) 2581-2590
24. Fan D., Bryan P.M., Antos L.K., Potthast R.J., and Potter L.R. Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: Guanylyl cyclase-linked natriuretic peptide receptors do not internalize. Mol. Pharmacol. 67 (2005) 174-183
25. Potter L.R., and Hunter T. Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J. Biol. Chem. 276 (2001) 6057-6060
26. Bryan P.M., and Potter L.R. The atrial natriuretic peptide receptor (NPR-A/GC-A) is dephosphorylated by distinct microcystin-sensitive and magnesium-dependent protein phosphatases. J. Biol. Chem. 277 (2002) 16041-16047
27. Jeon Y.H., Heo Y.S., Kim C.M., Hyun Y.L., Lee T.G., Ro S., and Cho J.M. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell. Mol. Life Sci. 62 (2005) 1198-1220
28. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., and Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52 (2000) 375-414
29. Funari V.A., Day A., Krakow D., Cohn Z.A., Chen Z., Nelson S.F., and Cohn D.H. Cartilage-selective genes identified in genome-scale analysis of non-cartilage and cartilage gene expression. BMC Genomics 8 (2007) 165
30. Gambaryan S., Palmetshofer A., Glazova M., Smolenski A., Kristjansson G.I., Zimmer M., and Lohmann S.M. Inhibition of cGMP-dependent protein kinase II by its own splice isoform. Biochem. Biophys. Res. Commun. 293 (2002) 1438-1444
31. Yasoda A., Komatsu Y., Chusho H., Miyazawa T., Ozasa A., Miura M., Kurihara T., Rogi T., Tanaka S., Suda M., Tamura N., Ogawa Y., and Nakao K. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10 (2004) 80-86
32. Tamura N., Doolittle L.K., Hammer R.E., Shelton J.M., Richardson J.A., and Garbers D.L. Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc. Natl. Acad. Sci. USA 101 (2004) 17300-17305
33. Tsuji T., and Kunieda T. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse. J. Biol. Chem. 280 (2005) 14288-14292
34. Matsukawa N., Grzesik W.J., Takahashi N., Pandey K.N., Pang S., Yamauchi M., and Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. USA 96 (1999) 7403-7408
35. Jaubert J., Jaubert F., Martin N., Washburn L.L., Lee B.K., Eicher E.M., and Guenet J.L. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc. Natl. Acad. Sci. USA 96 (1999) 10278-10283
36. Chikuda H., Kugimiya F., Hoshi K., Ikeda T., Ogasawara T., Shimoaka T., Kawano H., Kamekura S., Tsuchida A., Yokoi N., Nakamura K., Komeda K., Chung U.I., and Kawaguchi H. Cyclic GMP dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev. 18 (2004) 2418-2429
37. Mericq V., Uyeda J.A., Barnes K.M., De Luca F., and Baron J. Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatr. Res. 47 (2000) 189-193
38. Yasoda A., Ogawa Y., Suda M., Tamura N., Mori K., Sakuma Y., Chusho H., Shiota K., Tanaka K., and Nakao K. Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J. Biol. Chem. 273 (1998) 11695-11700
39. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16 (2002) 2813-2828
40. Kou I., and Ikegawa S. Sox9-dependent and -independent transcriptional regulation of human cartilage link protein. J. Biol. Chem. 279 (2004) 50942-50948
41. Lefebvre V., Huang W., Harley VV.R., Goodfellow P.N., and de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 17 (1997) 2336-2346
42. Panda D.K., Miao D., Lefebvre V., Hendy G.N., and Goltzman D. The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J. Biol. Chem. 276 (2001) 41229-41236
43. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., Nifuji A., and Noda M. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275 (2000) 10738-10744
44. Krejci P., Masri B., Fontaine V., Mekikian P.B., Weis M., Prats H., and Wilcox W.R. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J. Cell. Sci. 118 (2005) 5089-5100
45. Huang W., Zhou X., Lefebvre V., and de Crombrugghe B. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol. Cell. Biol. 20 (2000) 4149-4158
46. Passos-Bueno M.R., Wilcox W.R., Jabs E.W., Sertie A.L., Alonso L.G., and Kitoh H. Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat. 14 (1999) 115-125
47. Wilcox W.R., Tavormina P.L., Krakow D., Kitoh H., Lachman R.S., Wasmuth J.J., Thompson L.M., and Rimoin D.L. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am. J. Med. Genet. 78 (1998) 274-281
48. Suhasini M., Li H., Lohmann S.M., Boss G.R., and Pilz R.B. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway. Mol. Cell. Biol. 18 (1998) 6983-6994
49. Ozasa A., Komatsu Y., Yasoda A., Miura M., Sakuma Y., Nakatsuru Y., Arai H., Itoh N., and Nakao K. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36 (2005) 1056-1064
50. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., and Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84 (1996) 911-921
51. Hunt P.J., Richards A.M., Espiner E.A., Nicholls M.G., and Yandle T.G. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 78 (1994) 1428-1435